Abstract

The present disclosure relates to a novel process for the preparation of Elafibranor and its novel intermediate. The structure of Elafibranor of formula-1 is shown below:

Formula-1.

The present application also provides a crystalline form of Elafibranor and its process for the preparation.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS